XML 113 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2022
May 16, 2022
Equity Incentive Plan 2022        
Weighted Average Grant Date Fair Value        
Maximum number of shares authorized (in shares)       4,564,508
2022 Employee Stock Purchase Plan        
Weighted Average Grant Date Fair Value        
Maximum number of shares authorized (in shares) 184,010 184,010 184,010 184,010
Purchase price of common stock, percent 85.00%      
Stock Options        
Stock options activity        
Outstanding, beginning of period (in shares) 1,326,860 0    
Granted (in shares)     76,056  
Exercised (in shares)     (62,250)  
Cancelled / Forfeited (in shares)     (3,447)  
Outstanding, end of period (in shares) 1,175,853 1,175,853 1,175,853  
Vested and exercisable, end of period (in shares) 741,229 741,229 741,229  
Vested and expected to vest, end of period (in shares) 1,127,939 1,127,939 1,127,939  
Weighted Average Exercise Price        
Outstanding, beginning of period (in dollars per share)   $ 0    
Granted (in dollars per share)     $ 193.55  
Exercised (in dollars per share)     93.32  
Cancelled / Forfeited (in dollars per share)     138.78  
Outstanding, end of period (in dollars per share) $ 120.03 120.03 120.03  
Vested and exercisable, end of period (in dollars per share) 145.35 145.35 145.35  
Vested and expected to vest, end of period (in dollars per share) $ 118.86 $ 118.86 $ 118.86  
Weighted Average Remaining Contractual Term        
Outstanding, end of period     7 years 21 days  
Vested and exercisable, end of period     5 years 10 months 20 days  
Vested and expected to vest, end of period     6 years 11 months 26 days  
Aggregate Intrinsic Value        
Outstanding, beginning of period   $ 0    
Outstanding, end of period $ 75,597 75,597 $ 75,597  
Vested and exercisable, end of period 62,809 62,809 62,809  
Vested and expected to vest, end of period $ 73,865 $ 73,865 $ 73,865  
Weighted Average Grant Date Fair Value        
Expected life (in years)   5 years 2 months 12 days    
Weighted average fair value (in dollars per share)   $ 71.90    
Stock Options | Heritage AspenTech        
Weighted Average Exercise Price        
Granted (in dollars per share)     $ 193.35  
Stock Options | Emerson stock-based compensation plans        
Stock options activity        
Granted (in shares)     1,165,494  
Weighted Average Exercise Price        
Granted (in dollars per share)     $ 101.44  
Stock Options | Minimum        
Weighted Average Grant Date Fair Value        
Contractual terms   7 years    
Stock Options | Maximum        
Weighted Average Grant Date Fair Value        
Contractual terms   10 years    
Restricted Stock Units        
Stock options activity        
Outstanding, beginning of period (in shares) 504,386      
Restricted stock units activity        
Outstanding, beginning of period (in shares)   0    
Granted (in shares)     124,226  
Settled (in shares)     (87,930)  
Cancelled / Forfeited (in shares)     (5,149)  
Outstanding, end of period (in shares) 484,544 484,544 484,544  
Vested and expected to vest (in shares) 403,595 403,595 403,595  
Weighted Average Grant Date Fair Value        
Outstanding, beginning of period (in dollars per share)   $ 0    
Granted (in dollars per share)     $ 193.70  
Settled (RSUs) (in dollars per share)     188.32  
Cancelled / Forfeited (in dollars per share)     184.62  
Outstanding, end of period (in dollars per share) $ 188.45 $ 188.45 $ 188.45  
Vested and expected to vest, end of period (in dollars per share)     188.37  
Restricted Stock Units | Emerson stock-based compensation plans        
Restricted stock units activity        
Granted (in shares)     453,397  
Weighted Average Grant Date Fair Value        
Granted (in dollars per share)     $ 166.30